Dhampur Bio Organics Intrinsic Value
Dhampur Bio Organics (DBOL) median intrinsic value is ₹255.23 from 10 valuation models (range ₹50–₹306), vs current price ₹102.09 — +150.0% upside (Trading Below Calculated Value), margin of safety 60.0%. Read DBOL dividend yield for the complete payout history and dividend yield track record.
DBOL Valuation Methods Summary — DCF, Graham Number & P/E
Dhampur Bio Organics intrinsic value across 10 models vs current price ₹102.09 — upside/downside and value range per method. Analyse Dhampur Bio Organics shareholding analysis to track promoter, FII and institutional holdings.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹306.27 | ₹245.02 - ₹367.52 | +200.0% | EPS: ₹28.04, Sector P/E: 25x |
| Book Value Method | asset | ₹255.23 | ₹229.71 - ₹280.75 | +150.0% | Book Value/Share: ₹155.61, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹204.18 | ₹183.76 - ₹224.60 | +100.0% | Revenue/Share: ₹287.88, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹204.18 | ₹183.76 - ₹224.60 | +100.0% | EBITDA: ₹380.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹255.23 | ₹204.18 - ₹306.28 | +150.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹179.46 | ₹161.51 - ₹197.41 | +75.8% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹306.27 | ₹275.64 - ₹336.90 | +200.0% | Revenue Growth: 6.0%, Adj P/E: 18.5x |
| ROE Based Valuation | profitability | ₹204.18 | ₹183.76 - ₹224.60 | +100.0% | ROE: 17.9%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹306.27 | ₹275.64 - ₹336.90 | +200.0% | EPS: ₹28.04, BVPS: ₹155.61 |
| Dividend Yield Method | dividend | ₹50.00 | ₹45.00 - ₹55.00 | -51.0% | DPS: ₹1.50, Target Yield: 3.0% |
DBOL Intrinsic Value vs Market Price — All Valuation Models
Dhampur Bio Organics fair value range ₹50–₹306 vs current market price ₹102.09 across 10 valuation models. For current market price and key ratios, visit DBOL stock price BSE.
DBOL Intrinsic Value Analysis — Undervalued or Overvalued?
Dhampur Bio Organics median intrinsic value ₹255.23, current price ₹102.09 — Trading Below Calculated Value by 150.0%, margin of safety 60.0%.
What is the intrinsic value of DBOL?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Dhampur Bio Organics (DBOL) is ₹255.23 (median value). With the current market price of ₹102.09, this represents a +150.0% variance from our estimated fair value.
The valuation range spans from ₹50.00 to ₹306.27, indicating ₹50.00 - ₹306.27.
Is DBOL undervalued or overvalued?
Based on our multi-method analysis, Dhampur Bio Organics (DBOL) appears to be trading below calculated value by approximately 150.0%.
DBOL Financial Health — Key Ratios vs Industry Benchmarks
Dhampur Bio Organics financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.17 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 17.9% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 17.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.82x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
DBOL Cash Flow Quality — Operating & Free Cash Flow
Dhampur Bio Organics operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹220 Cr | ₹199 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹130 Cr | ₹57 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹-101 Cr | ₹-184 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹368 Cr | ₹264 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹-247 Cr | ₹-309 Cr | Negative Cash Flow | 3/10 |